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PR3 gene is actively transcribed in ANCA patients. (A) Schematic of 
PR3 gene and processed PR3 mRNA. Arrows mark the location of 
forward and reverse primers (FP and RP, respectively) used for RT-
PCR analysis of RNA immunoprecipitated with anti-RNA polymerase II 
antibody. (B) Ethidium bromide–stained agarose gel showed RT-PCR 
product specific for PR3 mRNA present in 4 of 6 ANCA patients. Lane 1, 
100-bp DNA ladder; lane 2, blank; lanes 3–8, ANCA patients; lane 9, 
water-only control.
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PR3 and MPO genes are depleted for H3K27me3 in neutrophils 
of ANCA vasculitis patients. (A–C) Quantitative ChIP analysis for 
H3K27me3 enrichment on chromatin isolated from neutrophils 
of healthy controls (white circles; n = 23) and ANCA vasculitis 
patients (black diamonds; n = 15) is shown for PR3 (A), MPO 
(B), and MYO-D (C). Levels of H3K27me3 immunoprecipitated 
chromatin are reported as percent of input DNA. 4 of 5 ANCA 
patients were clinically in remission (dashed ellipse); and 9 of 
the remaining 10 had active disease (Supplemental Table 1 
and Supplemental Figure 3). (D) Pearson correlation analysis 
of logarithmically transformed H3K27me3 levels at PR3 pro-
moter versus logarithmically transformed PR3 expression levels 
among ANCA patients (black diamonds, active; gray diamonds, 
remission) and healthy controls (white circles) showed a modest 
inverse correlation (r = –0.494; P = 0.0019). (E) Pearson cor-
relation analysis of logarithmically transformed H3K27me3 lev-
els at MPO promoter versus logarithmically transformed MPO 
expression levels among ANCA patients and healthy controls 
(symbols as in D) trended toward an inverse correlation, but 
was not statistically significant (r = –0.189; P = 0.264). Only 4 
ANCA patients in remission are shown because expression data 
for PR3 and MPO were not obtained for ANCA patient no. 1 
(Supplemental Table 1).
Table 1
DNA methylation status at PR3, MPO, and RUNX3 promoters in 
ANCA patients and healthy controls
	 Methylated	 Unmethylated
PR3
ANCA patients (n = 7) 0.9% ± 1.2% 99.1% ± 1.2%
Healthy controls (n = 3) 1.2% ± 0.5% 98.8% ± 0.5%
P 0.74 0.74
MPO
ANCA patients (n = 7) 5.6% ± 3.5% 94.4% ± 3.5%
Healthy controls (n = 3) 29.2% ± 22.0% 70.8% ± 22.0%
P 0.017 0.017
RUNX3
ANCA patients (n = 8) 91.1% ± 8.8%A 8.9% ± 8.8%
Healthy controls (n = 4) 74.5% ± 14.7%A 25.5% ± 14.7%
P 0.032 0.032
P values were determined by 2-tailed t test of the percentage of meth-
ylated or unmethylated DNA between ANCA patients and healthy 
controls. AReported as the sum of hypermethylated and intermediately 
methylated DNA (see Supplemental Methods).
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RUNX3 represses PR3 and MPO expression. Human myelocytic cell 
lines, which undergo myeloid differentiation when treated with 




























Expression of autoantigen and potential reg-
ulators. (A–D) Relative mRNA levels from 
total leukocytes of healthy controls (white 
circles; n = 49) and ANCA vasculitis patients 
(black diamonds; n = 97) were determined 
by quantitative RT-PCR with SYBR green 
(A and B) or Taqman (C and D). Mean fold 
change (horizontal bars) for patients versus 
controls was 1.77 ± 1.76 versus 1.00 ± 0.38 
for JMJD3 (A), 0.67 ± 0.54 versus 1.00 ± 
0.63 for RUNX3 (B), 19.77 ± 60.08 versus 
1.00 ± 1.58 for PR3 (C), and 9.27 ± 24.85 
versus 1.00 ± 0.78 for MPO (D). An outlier 
and its value (in parentheses) is shown for 
A. (E and F) Spearman ranked analysis 
of Affymetrix microarray data of healthy 
controls (white circles; n = 16) and ANCA 
patients (black diamonds; n = 25) showed 
an inverse correlation between RUNX3 
mRNA and PR3 mRNA (P < 0.001; E) and 
between RUNX3 mRNA and MPO mRNA 
(P < 0.001; F).
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Inverse correlation between RUNX3 
expression and PR3 or MPO expres-
sion results from coordinated changes in 
gene expression. (A–C) Relative mRNA 
levels for PR3, MPO, and RUNX3 from 
undifferentiated (white bars) or PMA-
differentiated (gray bars) human acute 
promyelocytic leukemia cell line HL60 
(A), acute monocytic leukemia cell line 
THP-1 (B), and histiocytic lymphoma 
(monocyte) cell line U937 (C) were 
determined by quantitative real-time 
RT-PCR with SYBR green (RUNX3) or 
Taqman (PR3 and MPO). Data repre-
sent median of 4–12 separate experi-
ments, with exact values shown below 
graphs. *P < 0.05, **P = 0.001 versus 
untreated, paired t test. (D) PR3 protein 
levels were determined by flow cytome-
try on undifferentiated (black histogram) 
or PMA-differentiated (gray histogram) 
U937 cells. (E) RUNX3 protein levels 
(arrow) were detected by Western blot 
in U937 cells that were undifferentiated 
or differentiated with PMA for 24 and 48 
hours. (F and G) H3K27me3 levels (F) 
and RUNX3 occupancy (G) at PR3 were 
determined by quantitative ChIP analy-
sis in undifferentiated (white bars) and 
PMA-differentiated (black bars) U937 
cells. Data (mean ± SD) represent per-
cent DNA input from 2 experiments, with 
exact values shown below graphs.
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Overexpression of RUNX3 in U937 myeloid cells 
silences PR3 expression. (A) Relative RUNX3 and 
PR3 mRNA levels in undifferentiated U937 cells and 
undifferentiated U937/P44 cells were determined 
by quantitative real-time RT-PCR with SYBR green 
(RUNX3) and Taqman (PR3). (B and C) Western 
blot analysis was performed to detect RUNX3 (B) 
and PR3 (C) protein in undifferentiated U937 and 
U937/P44 cells and in PMA-differentiated U937 cells 
as indicated. Lanes in B were run on the same gel 
but were noncontiguous (white line). (D) H3K27me3 
levels at PR3 were determined by quantitative ChIP 
analysis in undifferentiated U937 and U937/P44 cells. 
Data show percent DNA input for 3 separate experi-
ments, with exact values shown above bars.
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RUNX3 binds PR3 and MPO genes in 
myeloid cell lines and in ANCA patients 
in remission. (A) Consensus RUNX3 
binding sites in PR3 intron 4 and MPO 
intron 7 and 3′ UTR. (B) ChIP analysis 
for RUNX3 binding to PR3 intron 4 and 
MPO intron 7 in undifferentiated or 
PMA-differentiated U937 cells under 
the indicated immunoprecipitation con-
ditions. Normal rabbit serum was used 
in mock immunoprecipitation. Lanes 
were run on the same gel but were 
noncontiguous (white lines). (C–E) 
ChIP analysis for RUNX3 binding to 
MPO intron 7 and 3′ UTR (C and D) 
or to MPO intron 7 and PR3 intron 4 
(E) in neutrophils from an active 
ANCA vasculitis patient (C) and from 
ANCA vasculitis patients in remission 
(D and E). Relative mRNA levels were 
determined by Taqman quantitative 
RT-PCR for MPO and PR3 from total 
leukocytes of ANCA vasculitis patients 
and calculated as fold change relative 
to healthy control, with exact values 
shown above bars. Lanes in E were 
run on the same gel but were noncon-
tiguous (white line). 
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RUNX3 directly interacts with PRC2 subunits EZH2 and EED. Western 
blot analysis on immunoprecipitated proteins from undifferentiated and 
PMA-differentiated U937 cells (A and B) and THP-1 cells (C and D). 
Cell extracts were immunoprecipitated with anti-RUNX3 (A and C) or 
anti-EZH2 (B and D) Ab, and Western blots were performed with anti-
EZH2 (A and C), anti-RUNX3 (B and D), and anti-EED (A–D) Abs. 
Normal IgG was used in mock immunoprecipitations. Lanes in B were 
run on the same gel but were noncontiguous (white line). 
Figure 8
Mpo message level in peripheral neutrophils is insensitive to anti-
MPO IgG. Mouse Mpo mRNA levels from peripheral leukocytes were 
measured by quantitative real-time PCR, and ΔCt values were plotted 
against a standard curve of Mpo-positive cells serially diluted with 
Mpo-negative cells (see Methods and Supplemental Figure 5). Shown 
is Mpo message level for C57BL/6 and 129 mice not injected with 
anti-MPO IgG as well as for 129 mice 6 days after injection with anti-
MPO IgG. Data represent average of 2 biological replicates of Mpo 
levels from leukocytes that were purified and pooled for each category 
prior to isolating RNA.
research article
	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 120      Number 9      September 2010  3217















































































Model for PR3 and MPO gene silencing in normal neutrophils and 
disruption in ANCA vasculitis patients, highlighting the role of the 
H3K27me3 modification and enzymes that regulate this histone mark. 
(A) Granulocyte genes are silenced in normal mature circulating 
neutrophils. We hypothesize that maintenance of a transcriptionally 
silent state is a dynamic process. Inflammatory cytokines can induce 
JMJD3 (26). Our present demonstration of an interaction between 
RUNX3 and PRC2 subunits suggests RUNX3 can recruit EZH2 and 
reestablish H3K27me3. This epigenetic modification would maintain 
the transcriptionally silent state. (B) In neutrophils of ANCA vasculi-
tis patients, H3K27me3 is depleted at PR3 and MPO because of an 
unknown process, perhaps during neutrophil development. An alterna-
tive, but not mutually exclusive, possibility is that increased JMJD3 in 
ANCA patients reverses the silent state at PR3 and MPO by erasing 
the histone mark necessary for PcG-mediated silencing. Low levels of 
RUNX3 fail to recruit the EZH2 necessary to reestablish H3K27me3 
and maintain transcriptional silence. Furthermore, DNA methylation 
at MPO may also contribute to maintaining the transcriptionally silent 
state (not shown). An intriguing possibility is that PR3 and MPO are 
in a transcriptionally poised state marked by both H3K27me3 and 
H3K4me3 (59) in neutrophils of healthy individuals. In neutrophils of 
patients with ANCA vasculitis, depletion of H3K27me3 allows tran-
scription of PR3 and MPO.
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